APPSPIRE App in Preventing Students From Smoking

January 13, 2020 updated by: M.D. Anderson Cancer Center

APPSPIRE: Expanding the Reach of an Innovative Tobacco Control Program for Youth

This trial studies how well APPSPIRE, a smartphone app, works in preventing students from smoking. Technology-driven intervention programs, such as the APPSPIRE app, have the potential to increase access to health behavior treatments and therapies, such as tobacco cessation support, and provide effective prevention messaging.

Study Overview

Detailed Description

PRIMARY OBJECTIVES:

I. Develop a prototype of the APPSPIRE (phone application [app] of a smoking prevention interactive experience).

II. At post assessment, students enrolled in the study will qualitatively provide information about the usability and usefulness for the prevention and cessation sites.

III. Investigate frequency of use of and exposure to APPSPIRE modules via an objective measure of general use.

IV. Investigate how feasible the program will be. V. Obtain a maintained use of APPSPIRE with high completeness and extent of completion.

VI. Evaluate change in stage of change from baseline to about 1 and 4-month follow-ups among participants.

OUTLINE:

Participants attend an audio-taped focus group over 1 hour and are given the APPSPIRE app. After 1 and 4 months of using the app, participants complete a telephone survey over 1 hour to discuss how they liked the app and its usefulness.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • M D Anderson Cancer Center
      • Houston, Texas, United States, 77002
        • Houston Community College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 24 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Student at Houston Community College (HCC)
  • Speak and read English
  • Own an iPhone
  • Be enrolled in at least one class at HCC
  • Provide current contact information
  • Smoke 1 or more cigarettes a day (cessation group)
  • Have access to the internet (cessation and prevention/advocacy groups)
  • Evidence of smoking susceptibility as defined by the Smoking Susceptibility Scale

Exclusion Criteria:

  • Does not plan to continue as a student at their campus sometime during the year of the study (cessation and prevention/advocacy groups)
  • Current tobacco use (prevention/advocacy group)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prevention (focus group, APPSPIRE app, survey)
Participants attend an audio-taped focus group over 1 hour and are given the APPSPIRE app. After 1 and 4 months of using the app, participants complete a telephone survey over 1 hour to discuss how they liked the app and its usefulness.
Complete survey
Given APPSPIRE app
Other Names:
  • APPSPIRE Smartphone Application; APPSPIRE Smartphone App; APPSPIRE App; APPSPIRE Application
Attend focus group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of APPSPIRE application (app) use
Time Frame: Up to 4 months
Will be measured in minutes per day and with descriptive statistics. Will measure using mean, median and standard deviation for continuous variables.
Up to 4 months
The Feasibility of the tobacco control program.
Time Frame: Up to 4 months
Feasibly will be measured by multiplying the variable of two concepts: ease of use and ability to fit the program into routine schedules.
Up to 4 months
The Completeness with the Percentages of Participants surveyed.
Time Frame: Up to 4 months
Completeness will be measured as the percentage of participants who continue to use AppSPIRE until the 4 month follow up survey.
Up to 4 months
The extent of completion for the modules AppSPIRE.
Time Frame: Up to 4 months
The extent of completion includes the various modules of AppSPIRE. High extent of completion is obtained if 75% of the participants have completed all modules of AppSPIRE.
Up to 4 months
The Stages of the Change Scale
Time Frame: Baseline up to 4 months
A validated measure, The Stages of Change Scale, will be used to clarify smokers into 3 categories: pre-contemplation, contemplation and preparation.
Baseline up to 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexander V Prokhorov, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2013

Primary Completion (Actual)

January 8, 2020

Study Completion (Actual)

January 8, 2020

Study Registration Dates

First Submitted

October 16, 2013

First Submitted That Met QC Criteria

October 17, 2013

First Posted (Estimate)

October 22, 2013

Study Record Updates

Last Update Posted (Actual)

January 14, 2020

Last Update Submitted That Met QC Criteria

January 13, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2013-0369 (Other Identifier: M D Anderson Cancer Center)
  • P30CA016672 (U.S. NIH Grant/Contract)
  • NCI-2018-03054 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
  • R41DA035012 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Current Every Day Smoker

Clinical Trials on Survey Administration

3
Subscribe